LESLIE MYERS: Open Payments
NPI 1063652717 · GREENWOOD, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$641 in 39 payments from 12 companies in 2025. Trend: 2023 $227 · 2024 $554 · 2025 $641
Food & beverage: $641
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $159 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $76 |
| Astellas Pharma US Inc | 4 | $75 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $66 |
| Novo Nordisk Inc | 3 | $64 |
| Tris Pharma Inc | 3 | $49 |
| Collegium Pharmaceutical, Inc. | 2 | $39 |
| Corcept Therapeutics | 2 | $34 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $26 |
| OptumHealth Care Solutions, LLC | 1 | $18 |
Products named: VRAYLAR, CAPLYTA, Veozah, TRINTELLIX, Wegovy, QULIPTA, Dyanavel XR, Jornay PM.
Industry payments across SC — which companies pay providers there.
